Devine Michelle F, Kothapalli Naga, Elkhooly Mahmoud, Dubey Divyanshu
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Department of Neurology, University of Pittsburgh Medical Center, Pittsburg, PA, USA.
Ther Adv Neurol Disord. 2021 Feb 1;14:1756286420985323. doi: 10.1177/1756286420985323. eCollection 2021.
We provide an overview of the varied presentations of paraneoplastic neurological syndromes. We also review the onconeural antibodies and their particular oncological and neurological associations. Recognition of these syndromes and their oncological associations is crucial, as early diagnosis and management has been associated with better patient outcomes. Specific management strategies and prognosis vary widely depending on the underlying etiology. An understanding of the relevant clinical details, imaging findings, and other diagnostic information can help tailor treatment approaches. We provide an outline of the diagnostic evaluation and treatment of various paraneoplastic neurological disorders, presenting with central and/or peripheral nervous system involvement. We briefly discuss neurologic immune checkpoint inhibitor-related adverse events, which can occasionally present with paraneoplastic neurological syndrome phenotypes.
我们概述了副肿瘤性神经系统综合征的各种表现。我们还回顾了肿瘤神经抗体及其特定的肿瘤学和神经学关联。认识这些综合征及其肿瘤学关联至关重要,因为早期诊断和管理与更好的患者预后相关。具体的管理策略和预后因潜在病因的不同而有很大差异。了解相关的临床细节、影像学表现和其他诊断信息有助于制定合适的治疗方法。我们概述了各种累及中枢和/或周围神经系统的副肿瘤性神经疾病的诊断评估和治疗。我们简要讨论了与神经免疫检查点抑制剂相关的不良事件,这些不良事件偶尔可表现为副肿瘤性神经系统综合征的表型。